19Jun

Developing A Question (PICOT)-Central Venous Line Essay

Developing A Question (PICOT)-Central Venous Line Essay

Problem

A Central Venous Line is an appliance inserted to patients because of various reasons to administers patient’s parenteral nutrition, monitor the patients central venous pressure, administer drugs for instance cytotoxic drugs and antibiotic therapy, help in the diagnosis of cardiac failure, and monitor postoperative patients (Bodenham, 2008). 

For a considerable period, community healthcares and hospitals are now using the Central Venous Line device to administer High Dependency Category patients and postoperative patients (Bodenham, 2008). Practitioners now approve the use of device to administer patients with disorders such as arterial puncture and pneumothorax making the device most suitable for such patients with identified disorders. Practitioners insert the device to the right atrium or the superior vena cava through the internal jugular, femoral or subclavian veins by use of a strict procedure. Practitioners have to be careful since it may have complications that occur immediately after the insertion (Bodenham, 2008). Complications such as arterial puncture and pneumothorax require practitioners to be carefully for a better outcome of the patient. Therefore, central venous line device helps the practitioners to save the lives of patients with various disorders especially those brought about by heart disorders. Central venous line device becomes a solution for the identified problems (Bodenham, 2008).
Developing a Question (PICOT)
For patients with arterial puncture, pneumothorax, High Dependency Category patients, or postoperative patients (P), does the use of Central Venous Line device (I) helps in curing the disorders, which involve practitioners inserting the device in the right atrium or the superior vena cava (C) of patients considering the risk involved when administering patients with serious illness (0)?
References
Bodenham, A. (2008). Central Venous Catheters. New Jersey: John Wiley & Sons.